FTC says ViroPharma abused FDA petitioning process

The Federal Trade Commission sued Shire ViroPharma yesterday for allegedly manipulating the Food and Drug Administration citizen petition process to keep its monopoly on a gastrointestinal infection medicine.

Get unlimited access to all Global Competition Review content